This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Background References
1. Wang X. et. al. CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway. J Cancer. 2020 Jan
2. Kauer J. et. al. CD105 (Endoglin) as negative prognostic factor in AML. Sci Rep. 2019 Dec
Western blot analysis of CD105 on different lysates with Mouse anti-CD105 antibody (HA600077) at 1/1,000 dilution.
Lane 1: HeLa (Human cervical adenocarcinoma cell) cell lysate Lane 2: Hep G2 (Human hepatocellular carcinoma cell) cell lysate
Lysates/proteins at 10 µg/Lane. Exposure time: 30 seconds.
Blocking: 5% NFDM/TBST, 1 hour at room temperature Primary antibody: HA600077, 1/1,000 in 5% NFDM/TBST, 2 hour at room temperature Secondary antibody: Goat anti-mouse IgG-HRP (HA1006), 1/100,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 71 kDa Observed band size: 100-150 kDa
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"